Nabi Biopharmaceuticals (NASDAQ: NABI) announced today that it has successfully completed the manufacture and transfer of specified materials associated with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE